¡Ya estamos en ! Descubre más

Patterson Companies, Inc.

PDCO

Capitalización de mercado USD 2772 M

Excluida de cotización

PDCO dejó de cotizar en bolsa el 16 de abril de 2025.

Volver al ranking

Acerca de: Patterson Companies Inc is a dental distributor and wholesaler of consumable products and equipment operating through two business segments, Patterson Dental, and Patterson Animal Health. The company's segment includes Dental, Animal Health, and Corporate. It generates maximum revenue from the Animal Health segment. Geographically, it derives its revenue from the United States, the United Kingdom, and Canada. The firm derives almost all of its revenue from the United States.

Empleados: 7,600

Atención médica Distribución médica

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 0%

Neutral 0%

Negativo 0%

Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (NASDAQ: PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, “I would like to express my gratitude t.

Patterson Companies, Inc. Shareholders Approve Acquisition by Patient Square Capital

Zacks Investment Research

Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

Patterson Cos. (PDCO) reported earnings 30 days ago.

Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract

Patterson Companies' overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.

PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract

Zacks Investment Research

Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates

Patterson Cos. (PDCO) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.62 per share.

Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates

Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. “As we continue to progress toward closing our transaction with Patient Square Capital, our team remains focused on executing our strategy,” said Don Zurbay, President and CEO of Patterson Companies. “While our third quarter results were impacted by challenging market conditions, we remain confident in the long-term strength of Pat.

Patterson Companies Reports Fiscal 2025 Third Quarter Operating Results

PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns wheth.

PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders

Patterson Companies Announces Expiration of “Go-Shop” Period

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO), a leading dental and animal health distributor, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement, pursuant to which Patient Square Capital, L.P. (“Patient Square”), a dedicated health care investment firm, will acquire Patterson for $31.35 per share, in an all-cash transaction valued at approximately $4.1 billion, including the refinanc.

Patterson Companies Announces Expiration of “Go-Shop” Period

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders

Zacks Investment Research

PDCO Stock Gains on the News of Acquisition Deal With Patient Square

Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.

PDCO Stock Gains on the News of Acquisition Deal With Patient Square

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.

What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™